Ummmm.... Not to beat a dead horse or anything. Maybe Dr T didn't see this study from Ninth Annual American Association for Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research: Abstract B10. Presented November 11, 2010.Aromatase Inhibitor Adverse Effects Study focuses on "new onset" of symptoms
Aromatase inhibitors (or AIs) such as Arimidex, Aromasin and Femara are associated with the new onset of a wide array of symptoms according to a new study from the Prevention and Research Center at Mercy Medical Center in Baltimore, Maryland.
Randomized controlled trials of AIs have firmly established that musculoskeletal symptoms are related to treatment. But what about other symptoms that many women on AIs seem to experience?
The symptoms that are apparently associated with AIs are legion.
The study found that women taking AIs were:
- 5 times more likely to report having hot flashes, breast sensitivity, and chest pain than healthy women
- 4 times more likely to report night sweats, cold sweats, and hair loss
- about 3 times more likely to report leg cramps, weight gain, sleep disturbance, tendency to take naps, and forgetfulness.